Evexia Wealth’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.7M Buy
17,497
+27
+0.2% +$13.6K 2.39% 20
2025
Q4
$8.37M Sell
17,470
-576
-3% -$267K 2.34% 18
2025
Q3
$7.41M Buy
18,046
+2,589
+17% +$1M 2.22% 19
2025
Q2
$5.58M Buy
15,457
+5,699
+58% +$2.05M 1.75% 19
2025
Q1
$3.3M Buy
9,758
+10
+0.1% +$3.22K 1.2% 30
2024
Q4
$3.14M Buy
9,748
+601
+7% +$210K 1.06% 33
2024
Q3
$3.5M Buy
+9,147
New +$3.35M 1.24% 29

Other funds holding HCA

Evexia Wealth's HCA Position: Q1 2026 in Review

Evexia Wealth increased its HCA Healthcare (HCA) stake by 0.15% in Q1 2026, buying an estimated $13.6K and bringing the position to 17,497 shares worth $8.7M. The position accounts for 2.39% of the portfolio, ranked #20.

Evexia Wealth first reported a position in HCA in Q3 2024 and has held it in 7 quarters since. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Evexia Wealth held 17,497 shares of HCA Healthcare worth $8.7M as of Q1 2026.
  • Evexia Wealth bought 27 HCA Healthcare shares in Q1 2026, an estimated $13.6K.
  • HCA Healthcare made up 2.39% of Evexia Wealth's portfolio in Q1 2026, its #20 holding.
  • Evexia Wealth first reported a position in HCA Healthcare in Q3 2024 and has held it in 7 quarters since.
  • 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Evexia Wealth's 13F filing for Q1 2026, filed 16 Apr 2026.